BTC $62,424.86 -0.52%
ETH $1,742.65 -0.72%
BNB $570.83 +0.29%
XRP $1.09 -0.03%
SOL $78.01 -0.83%
TRX $0.3306 +0.28%
DOGE $0.0726 -0.02%
ADA $0.1681 -1.35%
BCH $235.74 -0.68%
LINK $7.68 -0.39%
HYPE $67.69 -0.91%
AAVE $87.79 -0.89%
SUI $0.7258 +1.37%
XLM $0.1822 -2.31%
ZEC $463.04 -4.06%
BTC $62,424.86 -0.52%
ETH $1,742.65 -0.72%
BNB $570.83 +0.29%
XRP $1.09 -0.03%
SOL $78.01 -0.83%
TRX $0.3306 +0.28%
DOGE $0.0726 -0.02%
ADA $0.1681 -1.35%
BCH $235.74 -0.68%
LINK $7.68 -0.39%
HYPE $67.69 -0.91%
AAVE $87.79 -0.89%
SUI $0.7258 +1.37%
XLM $0.1822 -2.31%
ZEC $463.04 -4.06%

The judge ruled that Bitfarms must immediately terminate its "poison pill" strategy aimed at opposing Riot Platforms' acquisition

2024-07-25 13:58:35
Collection

ChainCatcher news, the encrypted mining company Riot Platforms stated in a declaration on July 24 that the Ontario Capital Markets Tribunal issued a cease trading order on Bitfarms' poison pill plan, immediately terminating the strategy.

Since June 13, Bitfarms has been opposing Riot Platforms' $950 million acquisition offer, claiming that Riot unfairly undervalued the company. The company adopted a poison pill strategy known as a "rights plan" to attempt to block the acquisition.

Poison pill strategies are typically used by companies to prevent hostile takeovers. Under this strategy, existing shareholders purchase additional shares at a significant discount, diluting the value of the shares held by the acquirer. According to Bitfarms' now-defunct rights plan, if any entity acquires more than 15% of the company's outstanding shares before September 10, Bitfarms will issue new shares to other existing shareholders, thereby reducing that entity's ownership.

app_icon
ChainCatcher Building the Web3 world with innovations.